Riskpilot← Back to searchSign inGet full accessMediversitas Oy
OYActiveY-tunnus 2812257-9Kissankuja 13Web search portal activities · NACE 6391Est. 2017— employeeswww.mediversitas.fi
Revenue 2025
EUR 30K
+44% vs 2024
EBITDA margin
31.5%
+396% vs 2024
Equity ratio
-8.6%
Financial strength
Net profit 2025
EUR 9K
+397% vs 2024
| Revenue | EUR 30K | +44% |
| EBITDA | EUR 9K | +396% |
| Net profit | EUR 9K | +397% |
| Total assets | EUR 10K | -40% |
| Equity | EUR -843 | -137% |
| Employees | — | — |
Legal name
Mediversitas Oy
Y-tunnus number
2812257-9
Legal form
Osakeyhtiö
NACE code
6391 · Web search portal activities
Founded
1. helmikuuta 2017
Share capital
EUR 2 520
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
IT-konsultointia, IT-palveluja
Address
Kissankuja 13
Phone
+3580505356799
Email
info@mediversitas.fi
Website
www.mediversitas.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 9 | 8 | 22 | 21 | 30 |
| Staff expenses | — | — | −0 | −0 | −0 |
| EBITDA | 16 | 2 | 3 | −3 | 9 |
| Depreciation & amort. | — | — | −0 | −0 | −0 |
| EBIT | 16 | 2 | 3 | −3 | 9 |
| Net financials | −1 | −0 | 0 | −0 | 0 |
| Profit before tax | 15 | 2 | 3 | −3 | 9 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 15 | 2 | 3 | −3 | 9 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 13 | 5 | 7 | 16 | 10 |
| Equity | 2 | 4 | 5 | 2 | −1 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 11 | 1 | 2 | 14 | 11 |
| Total debt | 11 | 1 | 2 | 14 | 11 |
EBITDA margin
31.5%
This company
15.8%
Market median
+99% vs market
20212025
Equity ratio
-8.6%
This company
38.2%
Market median
-123% vs market
20212025
Return on equity
945400.0%
This company
18.4%
Market median
+5137943% vs market
20212025
Net profit margin
31.7%
This company
8.1%
Market median
+291% vs market
20212025
Asset turnover
3.06×
This company
1.12×
Market median
+173% vs market
20212025
Debt / equity
12.57×
This company
0.62×
Market median
-1927% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IM Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2018 | |
| Board of Directors | 2024 | |
| Chairperson | 2018 | |
| Board of Directors | 2021 | |
| Former (2) | ||
| Board of Directors | 2018 – 2021 | |
| Board of Directors | 2018 – 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mediversitas Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inka Merituuli Ikonen | Chief Executive Officer | 0 companies |
| Tanja Maria Pohjankoski | Board of Directors | 0 companies |
| Ahmed Abdulghani | Board of Directors | 0 companies |
| Anna Katariina Pälve | Chairperson | 0 companies |
| Hanna Kristiina Kunelius | Board of Directors | 0 companies |
| Suvi Marja Tuulia Siira | Board of Directors | 0 companies |
| Heidi Maria Kunelius | Board of Directors | 0 companies |